Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke

Atherosclerosis

Volumn 240, Issue 1, 2015, Pages 149-153

  Cloonan, Lisa ^a   Fitzpatrick, Kaitlin M ^a   Kanakis, Allison S ^a   Furie, Karen L ^a,b   Rosand, Jonathan ^a   Rost, Natalia S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Acute ischemic stroke; Blood biomarkers; Endothelial dysfunction; Hyperglycemia; Hyperhomocysteinemia; Small vessel disease; White matter hyperintensity

Indexed keywords

HEMOGLOBIN A1C; HOMOCYSTEINE; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

AGE; AGED; ALCOHOL CONSUMPTION; ALGORITHM; ARTICLE; BRAIN ISCHEMIA; CAUCASIAN; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ETHNICITY; FEMALE; FEMININITY; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NERVOUS SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TOBACCO USE; WHITE MATTER HYPERINTENSITY; WHITE MATTER LESION; WHITE MATTER VOLUME; BLOOD; LEUKOENCEPHALOPATHIES; MASSACHUSETTS; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SIGNAL PROCESSING; STATISTICAL MODEL; STROKE; UPREGULATION; VASCULAR ENDOTHELIUM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; BIOMARKERS; BOSTON; BRAIN ISCHEMIA; ENDOTHELIUM, VASCULAR; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOMOCYSTEINE; HUMANS; LEUKOENCEPHALOPATHIES; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SIGNAL PROCESSING, COMPUTER-ASSISTED; STROKE; UP-REGULATION;

EID: 84925002557     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.02.052     Document Type: Article

References (46)

1. Schmidt R., Fazekas F., Kleinert G., et al. Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Arch. Neurol. 1992, 49(8):825-827.
2. Debette S., Markus H.S. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010, 341:c3666.
3. Kuller L.H., Longstreth W.T., Arnold A.M., Bernick C., Bryan R.N., Beauchamp N.J. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 2004, 35(8):1821-1825.
4. Jeerakathil T., Wolf P.A., Beiser A., et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 2004, 35(8):1857-1861.
5. Han J.H., Wong K.S., Wang Y.Y., Fu J.H., Ding D., Hong Z. Plasma level of sICAM-1 is associated with the extent of white matter lesion among asymptomatic elderly subjects. Clin. Neurol. Neurosurg. 2009, 111:847-851.
6. Rost N.S., Rahman R., Sonni S., et al. Determinants of white matter hyperintensity volume in patients with acute ischemic stroke. J.Stroke Cerebrovasc. Dis. 2010, 19(3):230-235.
7. Hirase T., Node K. Endothelial dysfunction as a cellular mechanism for vascular failure. Am. J. Physiol. Heart Circ. Physiol. 2012, 302(3):H499-H505.
8. Liu D.S., Gao W., Liang E.S., et al. Effects of allicin on hyperhomocysteinemia-induced experimental vascular endothelial dysfunction. Eur. J. Pharmacol. 2013, 714(1-3):163-169.
9. Leung S.B., Zhang H., Lau C.W., Huang Y., Lin Z. Salidroside improves homocysteine-induced endothelial dysfunction by reducing oxidative stress. Evid. Based Complement. Altern. Med. 2013, 2013:679635.
10. Eringa E.C., Serne E.H., Meijer R.I., et al. Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes. Rev. Endocr. Metab. Disord. 2013, 14:39-48.
11. Verma S., Buchanan M., Anderson T. Endothelial function testing as a biomarker of vascular disease. Circulation 2003, 108:2054-2059.
12. El Oudi M., Bouguerra C., Aouni Z., et al. Homocysteine and inflammatory biomarkers plasma levels, and severity of acute coronary syndrome. Ann. Biol. Clin. Paris. 2011, 69(2):175-180.
13. Lorbeer R., Empen K., Dörr M., Arndt M., et al. Association between glycosylated haemoglobin A(1c) and endothelial function in an adult non-diabetic population. Atherosclerosis 2011, 217(2):358-363. http://www.ncbi.nlm.nih.gov/pubmed/21570686.
14. Cé G.V., Rohde L.E., da Silva A.M., et al. Endothelial dysfunction is related to poor glycemic control in adolescents with type 1 diabetes under 5 years of disease: evidence of metabolic memory. J.Clin. Endocrinol. Metab. 2011, 96(5):1493-1499.
15. Rost N.S., Rahman R.M., Biffi A., et al. White matter hyperintensity volume is increased in small vessel stroke subtypes. Neurology 2010, 75(19):1670-1677.
16. Topakian R., Barrick T.R., Howe F.A., Markus H.S. Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J.Neurol. Neurosurg. Psychiatr. 2010, 81(2):192-197.
17. Wardlaw J.M., Sandercock P.A.G., Dennis M.S., Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?. Stroke 2003, 34(3):806-812.
18. Wardlaw J.M., Farrall A., Armitage P.A., et al. Changes in background blood-brain barrier integrity between lacunar and cortical ischemic stroke subtypes. Stroke 2008, 39(4):1327-1332.
19. Wardlaw J.M., Doubal F.N., Valdes-Hernandez M., et al. Blood-brain barrier permeability and long-term clinical and imaging outcomes in cerebral small vessel disease. Stroke 2013, 44(2):525-527.
20. Hassan A., Hunt B.J., O'Sullivan M., et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003, 126(Pt 2):424-432.
21. Symons J.D., Abel E.D. Lipotoxicity contributes to endothelial dysfunction: a focus on the contribution from ceramide. Rev. Endocr. Metab. Disord. 2013, 14(1):59-68.
22. Jakubowski K. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J.Physiol. Pharmacol. 2008, 59(Suppl.9):155-167.
23. Böger R.H., Bode-Böger S.M., Sydow K., Heistad D.D., Lentz S.R. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1557-1564.
24. Chen S., Li N., Deb-Chatterji M., et al. Asymmetric dimethyarginine as marker and mediator in ischemic stroke. Int. J. Mol. Sci. 2012, 13:15983-16004.
25. Hoth K.F., Tate D.F., Poppas A., et al. Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke 2007, 38:308-312.
26. Vallance P., Leone A., Calver A., Collier J., Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J.Cardiovasc. Pharmacol. 1992, 20(Suppl.12):S60-S62.
27. Bai Y., Sun L., Du L., et al. Association of circulating levels of asymmetric dimethylarginine (ADMA) with carotid intima-media thickness: evidence from 6188 participants. Ageing Res. Rev. 2013, 12:699-707.
28. Singh A.S., Atam V., Chaudhary S.C., et al. Relation of glycated hemoglobin with carotid atherosclerosis in ischemic stroke patients: an observational study in Indian population. Ann. Indian Acad. Neurol. 2013, 16:185-189.
29. Jimenez-Conde J., Biffi A., Rahman R., et al. Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke. Stroke 2010, 41:437-442.
30. Pantoni L., Garcia J.H. Pathogenesis of leukoaraiosis: a review. Stroke 1997, 28:652-659.
31. Fein G., Shimotsu R., Di Sclafani V., Barakos J., Harper C. Increased white matter signal hyperintensities in long-term abstinent alcoholics compared to non-alcoholic controls. Alcohol Clin. Exp. Res. 2009, 33:70-78.
32. Mukamal K.J., Longstreth W.T., Mittleman M.A., Crum R.M., Siscovick D.S. Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults: the Cardiovascular Health Study. Stroke 2001, 32:1939-1946. http://www.ncbi.nlm.nih.gov/pubmed/11546878.
33. Collins M.A., Neafsey E.J., Mukamal K.J., et al. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin. Exp. Res. 2009, 33:206-209.
34. Papamichael C., Karatzis E., Karatzi K., et al. Red wine's antioxidants counteract acute endothelial dysfunction caused by cigarette smoking in healthy nonsmokers. Am. Heart J. 2004, 147:E5.
35. Haorah J., Knipe B., Leibhart J., Ghorpade A., Persidsky Y. Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction. J.Leukoc. Biol. 2005, 78:1223-1232.
36. Toda N., Ayajiki K. Vascular actions of nitric oxide as affected by exposure to alcohol. Alcohol Alcohol 2010, 45:347-355.
37. Collins M.A., Neafsey E.J. Neuroinflammatory pathways in binge alcohol-induced neuronal degeneration: oxidative stress cascade involving aquaporin, brain edema, and phospholipase A2 activation. Neurotox. Res. 2012, 21:70-78.
38. Yeh M.Y., Burnham E.L., Moss M., Brown L.A. Chronic alcoholism alters systemic and pulmonary glutathione redox status. Am. J. Respir. Crit. Care Med. 2007, 176:270-276.
39. Tiwari V., Chopra K. Resveratrol abrogates alcohol-induced cognitive deficits by attenuating oxidative-nitrosative stress and inflammatory cascade in the adult rat brain. Neurochem. Int. 2013, 62:861-869.
40. Wright C.B., Paik M.C., Brown T.R., et al. Total homocysteine is associated with white matter hyperintensity volume: the northern Manhattan study. Stroke 2005, 36:1207-1211.
41. Kissela B., Lindsell C.J., Kleindorfer D., et al. Clinical prediction of functional outcome after ischemic stroke: the surprising importance of periventricular white matter disease and race. Stroke 2009, 40:530-536.
42. Brickman A.M., Schupf N., Manly J.J., et al. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch. Neurol. 2008, 65:1053-1061.
43. Eikelboom J.W., Hankey G.J., Anand S.S., Lofthouse E., Staples N., Baker R.I. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2003, 31:1069-1075.
44. Kwon H.M., Lee Y.S., Bae H.J., Kang D.W. Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke. Stroke 2014, 45:871-873.
45. Chaiworapongsa T., Chaemsaithong P., Yeo L., Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat. Rev. Nephrol. 2014, 10(8):466-480.
46. Zhang C., Meng Y., Liu Q., et al. Injury to the endothelial surface layer induces glomerular hyperfiltration rats with early-stage diabetes. J.Diabetes Res. 2014, 2014:953740.